Jieping Chen

Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Exosomal microRNA biomarkers in ovarian cancer detection: systematic review and meta-analysis.

Exosomal microRNA biomarkers in ovarian cancer detection: systematic review and meta-analysis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 20, 2025

Nanoformulation-enabled CDDP/ICG combination for synergistic chemotherapy and photothermal therapy of ovarian cancer.

Nanoformulation-enabled CDDP/ICG combination for synergistic chemotherapy and photothermal therapy of ovarian cancer.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: July 24, 2025

Novel anatomical concept and standardized technique for single-port Paraaortic lymphadenectomy in gynecological cancers.

Novel anatomical concept and standardized technique for single-port Paraaortic lymphadenectomy in gynecological cancers.

Journal: Gynecologic oncology

Published: June 27, 2025

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer.

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer.

Journal: Cancer medicine

Published: June 18, 2024

Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.

Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.

Journal: Frontiers in genetics

Published: January 30, 2024

Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy.

Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy.

Journal: Discover oncology

Published: May 09, 2023

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.

Journal: The Journal of clinical investigation

Published: February 23, 2022

Long-term outcomes of individualized management after sentinel lymph-node biopsy for vulvar cancer.

Long-term outcomes of individualized management after sentinel lymph-node biopsy for vulvar cancer.

Journal: International journal of clinical oncology

Published: July 23, 2020

Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes.

Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes.

Journal: Cancer science

Published: August 12, 2017

Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification.

Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification.

Journal: Urologic oncology

Published: January 19, 2017

CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.

CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.

Journal: World journal of urology

Published: October 08, 2016

Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma.

Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma.

Journal: Oncoimmunology

Published: August 22, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026